Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT01483664

Communication Skills Intervention to Promote Transition Into Survivorship

The purpose of this study is to improve the communication skills of physicians who transition lymphoma cancer patients from the end of treatment to survivorship.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Moffitt Cancer Center, Tampa, Florida, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Physicians:

  • who treat patients with DLBCL and HD as per self report

Patients of Physicians:

  • have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology report or physician assessment in medical record and/or clinical judgment of the treating physician treated with curative intent.

For part 1 - have scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.

For part 2 (longitudinal phase): - have new scans indicating remission and completing planned chemotherapy and/or radiation therapy. The treating physician will determine that clinical remission has been achieved based on their best judgment.

  • be at least 18 years old
  • speak English well enough, in the judgment of the consenting professional, to be able to understand all aspects of the study, provide informed consent, and be able to complete all study measures.

Exclusion criteria

Physicians:

  • who do not have adequate patients in their clinical practice to meet the 8 patient enrollment requirement for patients with either DLBCL or HD as per self report

Patients of Physicians:

  • show evidence of cognitive impairment severe enough to preclude giving permission to the study staff, or completing the survey instruments of the study.
  • as per physician judgment, patient's prognosis and/or co-morbidities make them inappropriate for participation in a survivorship study.

For Part 2 ONLY (longitudinal phase):

  • those who consented to part 1, consult recording, of the study.

Treatment and study plan

Primary outcomes

  1. impact on patient outcomes of targeted physician communication skills training

    Time frame: 3 years

Secondary outcomes

  1. impact of a targeted CST intervention on the physicians

    Time frame: 3 years

    use of strategies, tasks and skills about transitioning lymphoma patients from the end of primary treatment to survivorship.

  2. describe communication during doctor-patient visits during the patients' first three years of survivorship

    Time frame: 3 years

    (MSKCC and MD Anderson baseline data only) The study team will look for qualitative themes to better understand the content of these conversations and the need for survivorship care planning. Half of these recordings were with MSKCC patients and physicians and half were with MD Anderson patients and physicians.

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Collaborators

  • H. Lee Moffitt Cancer Center and Research Institute
  • M.D. Anderson Cancer Center
  • Maimonides Medical Center
  • Monash University
  • National Cancer Institute (NCI)
  • New York Presbyterian Brooklyn Methodist Hospital
  • Rutgers University
  • San Francisco State University
  • Tampa General Hospital
  • University of California, Los Angeles
  • Weill Cornell Medical College in Qatar

Registry information

Important dates

Study start
2011
Primary completion
2026
Study completion
2026
First posted
Dec 1, 2011
Registry last updated
Jan 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.